Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07513389
Recruiting
Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Phase 2 · United States · 1 site
Registry update: 14 Sept 2026
NCT07685938
Recruiting
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Phase 2 · United States · 1 site
Registry update: 17 Sept 2026
NCT07693751
Recruiting
A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
Phase 1/2 · Belgium, Czechia, Spain, France, Moldova, United States · 9 sites
Registry update: 21 Sept 2026
NCT07639138
Recruiting
Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC
Phase 2 · China · 1 site
Registry update: 21 Sept 2026
NCT07889999
Recruiting
Clinical Profile of Patients With MASLD in Kazakhstan and Clinical Effectiveness of Ursosan in Almaty
Not applicable · Kazakhstan · 7 sites
Registry update: 22 Oct 2026
NCT07767175
Recruiting
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
Phase 1 · United States · 2 sites
Registry update: 4 Sept 2026
NCT07894458
Recruiting
MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer
Not applicable · China · 1 site
Registry update: 26 Oct 2026
NCT07557251
Recruiting
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma
Phase 1 · China · 1 site
Registry update: 31 Aug 2026
NCT07578324
Recruiting
TENS During Transperineal Prostate Biopsy
Not applicable · Poland · 1 site
Registry update: 13 Aug 2026
NCT07759895
Recruiting
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia
Phase 2 · Israel · 2 sites
Registry update: 29 Sept 2026
NCT07631156
Recruiting
STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
Phase 4 · South Korea · 5 sites
Registry update: 2 Sept 2026
NCT06898879
Recruiting
Enhancing Veteran-Clinical Collaboration in VA PRRCs
Not applicable · United States · 3 sites
Registry update: 19 Aug 2026
NCT07750262
Recruiting
Mobile Health Intervention to Increase Activity in Heart Failure Study
Not applicable · United States · 1 site
Registry update: 23 Oct 2026
NCT07790510
Recruiting
HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
Phase 1/2 · China · 1 site
Registry update: 27 Aug 2026
NCT07619131
Recruiting
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
Phase 3 · Bulgaria, Canada, Germany, Denmark, Spain, United Kingdom, Hungary, Israel, Poland, Ukraine, United States · 143 sites
Registry update: 10 Sept 2026
NCT07674264
Recruiting
Cross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PD
Not applicable · United States · 2 sites
Registry update: 21 Aug 2026
NCT07224269
Recruiting
Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis
Early phase 1 · United States · 1 site
Registry update: 9 Sept 2026
NCT07727083
Recruiting
Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases
Not applicable · China · 1 site
Registry update: 13 Aug 2026
NCT07424677
Recruiting
Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy
Phase 3 · Czechia, Greece, Italy, United States · 8 sites
Registry update: 15 Sept 2026
NCT07017686
Recruiting
The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis
Not applicable · Australia · 3 sites
Registry update: 2 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.